Identification of Arginine Phosphorylation in Mycolicibacterium smegmatis

Emmanuel C Ogbonna1, Henry R Anderson2, Karl R Schmitz1,2

  • 1Department of Biological Sciences, University of Delaware, Newark, Delaware, USA.

Microbiology Spectrum
|October 10, 2022
PubMed

Insights

This study confirms arginine phosphorylation in Mycobacterium smegmatis, a key modification for the essential ClpC1P1P2 protease. This finding supports phosphoarginine-mediated proteolysis as a potential drug target for tuberculosis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Tuberculosis remains a major global health threat, with multidrug-resistant strains necessitating novel drug targets.
  • The ATP-dependent protease ClpC1P1P2 is essential for mycobacterial viability, but its substrates are poorly understood.
  • Previous research in Bacillus subtilis indicated that ClpCP proteases recognize arginine phosphorylation, but this modification's presence in mycobacteria was unconfirmed.

Purpose of the Study:

  • To investigate the existence and role of posttranslational arginine phosphorylation in mycobacteria.
  • To identify potential substrates of the ClpC1P1P2 protease in mycobacteria.
  • To explore the potential of arginine phosphorylation as a target for new anti-tuberculosis drugs.

Main Methods:

  • Utilized a phosphopeptide enrichment workflow.
  • Employed shotgun phosphoproteomics to analyze the proteome of Mycolicibacterium smegmatis.
  • Identified specific arginine phosphosites on various proteins.

Main Results:

  • Confirmed the presence of posttranslational arginine phosphorylation in Mycolicibacterium smegmatis.
  • Identified arginine phosphosites on functionally diverse proteins within the M. smegmatis proteome.
  • Observed that phosphoarginine modifications are not upregulated by heat stress, suggesting distinct roles compared to Bacillus species.

Conclusions:

  • Provides strong evidence for the existence of phosphoarginine modifications in mycobacteria.
  • Supports the hypothesis that ClpC1P1P2 utilizes phosphoarginine-mediated proteolysis in mycobacteria and other actinobacteria.
  • Highlights a promising avenue for developing new therapeutic strategies against drug-resistant tuberculosis.